The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

NCT ID: NCT06593405

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-22

Study Completion Date

2026-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Age-Related Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a quasi-experimental study to determine outcomes with occupational therapy (OT) medication management interventions/strategies for persons with Age-related Macular Degeneration (AMD)
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Receiving OT interventions

All participants will receive all OT interventions

Group Type EXPERIMENTAL

occupational therapy interventions for low vision care

Intervention Type COMBINATION_PRODUCT

Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

occupational therapy interventions for low vision care

Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clients with AMD, DR or Glaucoma
* Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Exclusion Criteria

* Clients with other age related eye diseases other than AMD, DR or Glaucoma.
* Clients who do not wish to participate in this study.
Minimum Eligible Age

50 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MCPHS University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michelle Dowling, OTD

Role: PRINCIPAL_INVESTIGATOR

MCPHS University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MCPHS 10 Lincoln Square

Worcester, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michelle Dowling, OTD

Role: CONTACT

508-373-5851

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michelle Dowling, Clinical Doctorate (OTD)

Role: primary

508-373-5851

References

Explore related publications, articles, or registry entries linked to this study.

Occupational Therapy's Role in Medication Management. Am J Occup Ther. 2017 Nov/Dec;71(Supplement_2):7112410025p1-7112410025p20. doi: 10.5014/ajot.2017.716S02. No abstract available.

Reference Type BACKGROUND
PMID: 29309002 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.aota.org/publications/ot-practice/ot-practice-issues/2020/medication-adherence

American Occupational Therapy Association link to professional information

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-2023-2024-84

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Changes in Eye Shape With Myopia Management Interventions
NCT06450132 ACTIVE_NOT_RECRUITING PHASE4
Low-Dose Atropine for Treatment of Myopia
NCT03334253 COMPLETED PHASE3
Low-dose Atropine for Myopia Control in Children
NCT03865160 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
Study of OT-101 in Treating Myopia
NCT04770610 ACTIVE_NOT_RECRUITING PHASE3
Early Intervention for Premyopic Children
NCT06200194 ACTIVE_NOT_RECRUITING PHASE2